tinnitus/nausea

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 245 rezilta yo

Etiology of dizziness, tinnitus, and nausea in idiopathic intracranial hypertension.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tinnitus after administration of sublingual immunotherapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis. The most common side effects are of oropharyngeal and gastrointestinal in nature, for example,

Tinnitus: Our experience with intratympanic instillation of 2% Xylocaine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Idiopathic subjective tinnitus is quite an obscure otopathology for over the decades. This paper deals with the results of an intratympanic instillation of 2% Xylocaine through Grommet over a six weeks time. Patients overall compliance was 26%. We suggest this method of treatment for those who have

Recurrent atrial fibrillation with nausea and vomiting.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Atrial fibrillation occurred twice during episodes of severe nausea and vomiting in a previously healthy 40-year-old male with new onset of Meniere's syndrome (tinnitus, vertigo, deafness). No organic cause was identified to explain the arrhythmia. Holter monitoring, maximal treadmill stress

Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tinnitus is an otological symptom that is encountered often, yet its treatment is difficult. If tinnitus is of cochlear origin, a reasonable assumption is that a total depression of the cochlear function will abolish cochlear tinnitus. To achieve this depression, transtympanic infusion of a local

Evaluation of amino-oxyacetic acid as a palliative in tinnitus.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Amino-oxyacetic acid (AOAA) was evaluated as a palliative in tinnitus. Sixty-six patients with tinnitus presumed to be of cochlear origin were given either a placebo or 75 mg of AOAA four times a day for 1 week. Response was evaluated by both audiometric measurement of tinnitus loudness and

Neurootological differentiations in endogenous tinnitus.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Vertigo and tinnitus are very frequent complaints. Often, we find multisensory syndromes combined with tinnitus, hearing impairment, vertigo, and nausea. From more than 10,000 cases, we evaluated 757 randomly selected neurootological patients suffering from endogenous tinnitus. First, we classified

Tonic tensor tympani syndrome in tinnitus and hyperacusis patients: a multi-clinic prevalence study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tonic tensor tympani syndrome (TTTS) is an involuntary, anxiety-based condition where the reflex threshold for tensor tympani muscle activity is reduced, causing a frequent spasm. This can trigger aural symptoms from tympanic membrane tension, middle ear ventilation alterations and trigeminal nerve

A Case Report on Red Ear Syndrome with Tinnitus Successfully Treated with Transcranial Random Noise Stimulation.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The red ear syndrome represents a rare symptom complex consisting of auricular erythema associated with painful and burning sensations. It has been described in combination with tinnitus rarely. It has been hypothesized to be etiologically related to altered trigeminal afferent input,

A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A sequential double blind cross-over trial of tocainide hydrochloride, an oral analogue of lignocaine, is reported. The dosage of tocainide hydrochloride ranged from 200-600 mg daily. Of the 32 patients who completed the trial, 1 had complete relief and 2 had partial relief of their tinnitus whilst

Gingko biloba (Rökan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tinnitus is one of the most important symptoms in neurootology after vertigo, nausea, and hearing loss. In most cases, the origin of the tinnitus remains inexplicable. Well-known, however, is that tinnitus may arise in any part of the hearing pathway (i.e., both within the cochlea receptor and in

Cisplatin and 5-fluorouracil in advanced cancer of the penis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A total of 8 patients with advanced squamous cell carcinoma of the penis (Jackson stages III and IV) received chemotherapy with 100 mg./m2. cisplatin intravenously on day 1 and a 24-hour infusion of 1,000 mg./m.2 5-fluorouracil on days 1 to 5. Of the patients 2 (25%) achieved a partial response: 1

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tirapazamine (SR 4233; 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide) is a bioreductive agent exhibiting up to 200 x greater toxicity for hypoxic cells as compared to oxygenated cells. In murine studies, a selective increase in tumor kill was observed when tirapazamine was coadministered with other

[A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In this study the multicenter, fixed-flexible dose regimen was taken to evaluate the effective dose range of Terazosin for the treatment of micturition disturbance in benign prostatic hypertrophy (BPH) and to clarify the characteristics of patients who are more responsive to Terazosin therapy. After

[Triple semicircular canal occlusion with cochlear implantation for delayed endolymphatic hydrops: a case report].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A 46-year-old female with profound sensorineural hearing loss in her left ear from childhood developed tinnitus and fluctuating hearing loss on the right side 8 years ago. Four years later, paroxysmal episodes of rotatory vertigo occurred with gradually increased frequency, lasting from half an hour

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye